Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06869044 · ClinicalTrials.gov registry record · NA
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
A NA study of Myopia and Presbyopia, sponsored by CooperVision International Limited (CVIL).
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT06869044: Recruiting NA study of Myopia and Presbyopia, sponsored by CooperVision International Limited (CVIL).
NCT06869044 is a NA study of Myopia and Presbyopia that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 66 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06869044, a NA study of Myopia and Presbyopia, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.
Primary Outcome
Overall Impression recorded on a visual analog scale of 0 to 100 where (0=Extremely poor. Unmanageable. Cannot use lenses, 100=Excellent. Highly impressed with these lenses overall.)
Conditions Studied
Interventions
- DEVICE omafilcon A lens
- DEVICE Low ADD power somofilcon A lens
- DEVICE Medium ADD power somofilcon A lens
- DEVICE High ADD power somofilcon A lens
Study Locations (1)
California
- University of California, Berkeley, CA - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What NCT06869044 shows while recruiting
NCT06869044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 4 interventions - of which omafilcon A lens is the first listed.
NCT06869044 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06869044 about?
NCT06869044 is a clinical study titled "A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add". The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.
What is the current status of trial NCT06869044?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-02-11. Estimated completion is 2025-04-30.
What conditions does trial NCT06869044 study?
This clinical trial studies the following conditions: Myopia, Presbyopia, Hyperopia.
What interventions are being tested in trial NCT06869044?
The interventions under investigation include: omafilcon A lens (DEVICE), Low ADD power somofilcon A lens (DEVICE), Medium ADD power somofilcon A lens (DEVICE), High ADD power somofilcon A lens (DEVICE).
Who is sponsoring clinical trial NCT06869044?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06869044 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06869044's enrollment target sits among peer trials
66 53rd of 90 higher than 35 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI